Proactive Infliximab Monitoring Improves the Rates of Transmural Remission in Crohn’s Disease: A Propensity Score–Matched Analysis

Abstract Background Few patients can reach transmural remission in Crohn’s disease (CD) with currently available therapies. Proactive optimization of infliximab (IFX) based on trough levels may potentially improve these results. Methods Retrospective cohort study including consecutive CD patients st...

Full description

Saved in:
Bibliographic Details
Published inInflammatory bowel diseases
Main Authors Fernandes, Samuel Raimundo, Bernardo, Sónia, Saraiva, Sofia, Rita Gonçalves, Ana, Moura Santos, Paula, Valente, Ana, Araújo Correia, Luís, Cortez-Pinto, Helena, Magro, Fernando
Format Journal Article
LanguageEnglish
Published 20.11.2023
Online AccessGet full text

Cover

Be the first to leave a comment!
You must be logged in first